Document Type

Patent

Patent Number

US Patent 9,238,040

Patent agency

United States Patent and Trademark Office

Publication Date

1-19-2016

Assignee

Rutgers, the State University of New Jersey (New Brunswick, NJ, US) ; University of Iowa Research Foundation (Iowa City, IA, US)

Application Number

11/914,849

Date Filed

2006-05-17

Total Pages

19 pages

Abstract

A method for preventing colorectal cancer in a patient possessing human tropomyocin isoform TC22 is disclosed. The method comprises: (a) detecting a serum protein concentration of TC22 in a patient and (b) administering to said patient prior to detecting colorectal cancer in said patient a therapeutically effective amount of a chemotherapeutic composition comprising a chemotherapeutic compound that reduces the level of TC22, wherein the chemotherapeutic compound is selected from the group consisting of sulfasalazine, 5-amino-2-hydroxybenzoic acid, osalazine, and balsalazide.

Share

COinS
 

URL

https://ir.uiowa.edu/patents/652